We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
About Biomedical Basics
Biomedical Basics are AI-generated explanations prepared with access to the complete collection, human-reviewed prior to publication. Short and simple, covering biomedical and life sciences fundamentals.
Topics Covered
- CRISPR-Cas9 basics
- Bacterial defense origins
- DNA targeting mechanism
- Research and medical uses
- Risks and ethics in genome editing
- Societal and regulatory issues
- Future of genome engineering
Talk Citation
(2025, November 30). CRISPR-Cas9 and gene editing [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 4, 2025, from https://doi.org/10.69645/ITQX5782.Export Citation (RIS)
Publication History
- Published on November 30, 2025
Financial Disclosures
A selection of talks on Infectious Diseases
Transcript
Please wait while the transcript is being prepared...
0:00
The following session
will cover CRISPR-Cas9
and Gene Editing Basics
within the context
of this subject,
focusing on the basics
of CRISPR-Cas9,
its origins as a
bacterial defense system,
and how it enables
precise gene editing.
We will discuss the
molecular mechanism by which
CRISPR-Cas9 targets
and alters DNA,
as well as its wide-ranging
applications in research,
medicine, and agriculture.
The presentation will
address the key risks,
ethical concerns, and
societal debates surrounding
this technology.
Finally, we will explore future
advancements and the importance
of balancing innovation with
responsibility in
genome engineering..
To begin, CRISPR-Cas-nine is a
powerful gene-editing tool.
CRISPR stands for
Clustered Regularly
Interspaced Short
Palindromic Repeats,
a natural defense
system in bacteria.
It acts as adaptive immunity,
enabling bacteria to store
viral DNA snippets in
their genome to recognize
and combat repeat invaders.
The Cas-nine enzyme functions
as molecular scissors
for gene editing.
Together, CRISPR and
Cas-nine allow scientists
to target DNA sequences with
unprecedented precision,
greatly accelerating
genetic research.
The true power of
CRISPR-Cas-nine lies in
its ability to target
specific DNA sequences
within the genome.
Guided by a designed
RNA molecule,
the Cas-nine enzyme is directed to
the desired DNA site,
where it creates a
double-stranded break.
The cell detects this break
and tries to repair it.